326 related articles for article (PubMed ID: 10651943)
1. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
2. CD95 ligand expression in dedifferentiated breast cancer.
Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
Strand S; Hofmann WJ; Hug H; Müller M; Otto G; Strand D; Mariani SM; Stremmel W; Krammer PH; Galle PR
Nat Med; 1996 Dec; 2(12):1361-6. PubMed ID: 8946836
[TBL] [Abstract][Full Text] [Related]
5. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions.
Accornero P; Radrizzani M; Delia D; Gerosa F; Kurrle R; Colombo MP
Blood; 1997 Jan; 89(2):558-69. PubMed ID: 9002959
[TBL] [Abstract][Full Text] [Related]
8. Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis.
Hasel C; Rau B; Perner S; Sträter J; Möller P
Lab Invest; 2001 Mar; 81(3):317-26. PubMed ID: 11310825
[TBL] [Abstract][Full Text] [Related]
9. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation.
Müschen M; Warskulat U; Peters-Regehr T; Bode JG; Kubitz R; Häussinger D
Gastroenterology; 1999 Mar; 116(3):666-77. PubMed ID: 10029626
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.
Canaday DH; Wilkinson RJ; Li Q; Harding CV; Silver RF; Boom WH
J Immunol; 2001 Sep; 167(5):2734-42. PubMed ID: 11509617
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D
Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158
[TBL] [Abstract][Full Text] [Related]
14. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of gammadelta T cells to cause apoptosis.
Manfredi AA; Heltai S; Rovere P; Sciorati C; Paolucci C; Galati G; Rugarli C; Vaiani R; Clementi E; Ferrarini M
Eur J Immunol; 1998 Jun; 28(6):1798-806. PubMed ID: 9645360
[TBL] [Abstract][Full Text] [Related]
16. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
Alexander CE; Kaye PM; Engwerda CR
Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
Wilson AD; Redchenko I; Williams NA; Morgan AJ
Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
[TBL] [Abstract][Full Text] [Related]
18. Defining CD95 as a tumor suppressor gene.
Müschen M; Warskulat U; Beckmann MW
J Mol Med (Berl); 2000; 78(6):312-25. PubMed ID: 11001528
[TBL] [Abstract][Full Text] [Related]
19. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand.
Ng CS; Lo ST; Chan JK
Hum Pathol; 1999 Jan; 30(1):48-53. PubMed ID: 9923926
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.
Sasaki Y; Ami Y; Nakasone T; Shinohara K; Takahashi E; Ando S; Someya K; Suzaki Y; Honda M
Clin Exp Immunol; 2000 Dec; 122(3):381-9. PubMed ID: 11122244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
